TKT
Basic information
Region (hg38): 3:53224712-53256052
Links
Phenotypes
GenCC
Source:
- transketolase deficiency (Strong), mode of inheritance: AR
- transketolase deficiency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Short stature, developmental delay, and congenital heart defects | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Musculoskeletal; Neurologic | 27259054 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TKT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 19 | ||||
missense | 39 | 45 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 8 | |||||
Total | 0 | 2 | 41 | 19 | 14 |
Variants in TKT
This is a list of pathogenic ClinVar variants found in the TKT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-53225769-A-T | not specified | Uncertain significance (Apr 18, 2024) | ||
3-53225833-C-G | not specified | Uncertain significance (Aug 23, 2021) | ||
3-53225835-G-T | See cases | Uncertain significance (Mar 21, 2022) | ||
3-53225838-T-C | Benign (Dec 31, 2019) | |||
3-53225846-T-C | Benign (Dec 31, 2019) | |||
3-53225857-G-A | not specified | Uncertain significance (Nov 10, 2023) | ||
3-53225869-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
3-53225883-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
3-53225911-A-T | not specified | Uncertain significance (Jun 06, 2023) | ||
3-53225980-G-A | Transketolase deficiency | Benign (Sep 10, 2021) | ||
3-53226761-T-C | not specified | Uncertain significance (Apr 22, 2022) | ||
3-53226803-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
3-53226848-A-T | Transketolase deficiency | Uncertain significance (Jan 06, 2021) | ||
3-53228076-G-A | not specified | Uncertain significance (Oct 19, 2021) | ||
3-53228089-C-T | Transketolase deficiency | Uncertain significance (Jun 01, 2018) | ||
3-53228090-G-C | TKT-related disorder | Likely benign (Mar 31, 2018) | ||
3-53228109-C-A | not specified | Uncertain significance (Apr 25, 2022) | ||
3-53228116-C-T | not specified | Uncertain significance (Dec 17, 2021) | ||
3-53228149-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
3-53228287-C-T | Uncertain significance (Apr 03, 2019) | |||
3-53228343-C-T | not specified | Uncertain significance (May 10, 2022) | ||
3-53229018-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-53229019-G-C | Likely benign (Nov 18, 2017) | |||
3-53229049-G-A | Likely benign (May 31, 2018) | |||
3-53229096-T-C | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TKT | protein_coding | protein_coding | ENST00000423516 | 15 | 31346 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00675 | 0.993 | 125710 | 0 | 38 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 306 | 399 | 0.766 | 0.0000250 | 4152 |
Missense in Polyphen | 126 | 188.46 | 0.66858 | 1904 | ||
Synonymous | -0.427 | 174 | 167 | 1.04 | 0.0000115 | 1237 |
Loss of Function | 3.31 | 9 | 27.9 | 0.323 | 0.00000128 | 344 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000304 | 0.000304 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. {ECO:0000269|PubMed:27259054}.;
- Disease
- DISEASE: Short stature, developmental delay, and congenital heart defects (SDDHD) [MIM:617044]: An autosomal recessive syndrome characterized by short stature, developmental delay, intellectual disability and congenital heart defects including ventricular septal defect, atrial septal defect and patent foramen ovale. Cataract and uveitis are observed in some patients. {ECO:0000269|PubMed:27259054}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pentose phosphate pathway - Homo sapiens (human);Warburg Effect;Pentose Phosphate Pathway;Glucose-6-phosphate dehydrogenase deficiency;Ribose-5-phosphate isomerase deficiency;Transaldolase deficiency;Pentose Phosphate Pathway;Pentose phosphate pathway (hexose monophosphate shunt);Metabolism of carbohydrates;Insulin effects increased synthesis of Xylulose-5-Phosphate;Metabolism;Pentose phosphate cycle;pentose phosphate pathway (non-oxidative branch);pentose phosphate pathway;EGFR1;Integration of energy metabolism
(Consensus)
Recessive Scores
- pRec
- 0.459
Intolerance Scores
- loftool
- 0.172
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.7
Haploinsufficiency Scores
- pHI
- 0.705
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.885
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tkt
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; renal/urinary system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- xylulose biosynthetic process;pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch;regulation of growth;glyceraldehyde-3-phosphate biosynthetic process
- Cellular component
- nucleoplasm;peroxisome;cytosol;nuclear body;nuclear speck;vesicle;myelin sheath;extracellular exosome
- Molecular function
- transketolase activity;protein binding;protein homodimerization activity;metal ion binding;cofactor binding